Literature DB >> 3247289

Enhancement of colonic drug absorption by the transcellular permeation route.

M Tomita1, M Hayashi, T Horie, T Ishizawa, S Awazu.   

Abstract

The effects of sodium caprate and sodium caprylate on transcellular permeation routes were examined in rats. The release of membrane phospholipids was significantly increased only by caprate, while protein release did not change from the control in the presence of caprate or caprylate, indicating that the extent of membrane disruption was insufficient to account for enhanced permeation. Using brush border membrane (BBM) vesicles prepared from colon, with their protein and lipid component labeled by fluorescent probes, the perturbing actions of caprate and caprylate toward the membrane were examined by fluorescence polarization. Caprate interacted with membrane protein and lipids, and caprylate mainly with protein, causing perturbation to the membrane. The release of 5(6)-carboxyfluorescein previously included in BBM vesicles was increased by caprate but not by caprylate. These results suggest that caprate enhances permeability via the transcellular route through membrane perturbation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3247289     DOI: 10.1023/a:1015992819290

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  17 in total

1.  Measurement of protein rotational diffusion in membranes by flash photolysis.

Authors:  R J Cherry
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

2.  Difference in microviscosity induced by different cholesterol levels in the surface membrane lipid layer of normal lymphocytes and malignant lymphoma cells.

Authors:  M Shinitzky; M Inbar
Journal:  J Mol Biol       Date:  1974-01-05       Impact factor: 5.469

3.  Drug absorption. I. An in situ rat gut technique yielding realistic absorption rates.

Authors:  J T Doluisio; N F Billups; L W Dittert; E T Sugita; J V Swintosky
Journal:  J Pharm Sci       Date:  1969-10       Impact factor: 3.534

Review 4.  Barrier function of epithelia.

Authors:  D W Powell
Journal:  Am J Physiol       Date:  1981-10

5.  Enhanced rectal absorption of theophylline, lidocaine, cefmetazole, and levodopa by several adjuvants.

Authors:  T Nishihata; J H Rytting; T Higuchi
Journal:  J Pharm Sci       Date:  1982-08       Impact factor: 3.534

6.  Effects of salicylic acid on the permeability of the plasma membrane of the small intestine of the rat: a fluorescence spectroscopic approach to elucidate the mechanism of promoted drug absorption.

Authors:  H Kajii; T Horie; M Hayashi; S Awazu
Journal:  J Pharm Sci       Date:  1986-05       Impact factor: 3.534

7.  Differences in the promotion mechanism of the colonic absorption of antipyrine, phenol red and cefmetazole.

Authors:  M Shiga; M Hayashi; T Horie; S Awazu
Journal:  J Pharm Pharmacol       Date:  1987-02       Impact factor: 3.765

8.  Fluorescence study of the membrane-perturbing action of sodium caprylate as related to promotion of drug absorption.

Authors:  H Kajii; T Horie; M Hayashi; S Awazu
Journal:  J Pharm Sci       Date:  1988-05       Impact factor: 3.534

9.  Comparison of the effects of sodium salicylate, disodium ethylenediaminetetraacetic acid and polyoxyethylene-23-lauryl ether as adjuvants for the rectal absorption of sodium cefoxitin.

Authors:  T Nishihata; H Tomida; G Frederick; J H Rytting; T Higuchi
Journal:  J Pharm Pharmacol       Date:  1985-03       Impact factor: 3.765

10.  Salicylate-promoted permeation of cefoxitin, insulin and phenylalanine across red cell membrane. Possible mechanism.

Authors:  T Nishihata; T Higuchi; A Kamada
Journal:  Life Sci       Date:  1984-01-30       Impact factor: 5.037

View more
  11 in total

1.  Water-in-oil microemulsions containing medium-chain fatty acids/salts: formulation and intestinal absorption enhancement evaluation.

Authors:  P P Constantinides; G Welzel; H Ellens; P L Smith; S Sturgis; S H Yiv; A B Owen
Journal:  Pharm Res       Date:  1996-02       Impact factor: 4.200

2.  Differences in the enhancing effects of sodium caprate on colonic and jejunal drug absorption.

Authors:  M Tomita; T Sawada; T Ogawa; H Ouchi; M Hayashi; S Awazu
Journal:  Pharm Res       Date:  1992-05       Impact factor: 4.200

3.  Mechanistic analysis of chemical permeation enhancers for oral drug delivery.

Authors:  Kathryn Whitehead; Samir Mitragotri
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

4.  Intestinal transport of gentamicin with a novel, glycosteroid drug transport agent.

Authors:  H R Axelrod; J S Kim; C B Longley; E Lipka; G L Amidon; R Kakarla; Y W Hui; S J Weber; S Choe; M J Sofia
Journal:  Pharm Res       Date:  1998-12       Impact factor: 4.200

5.  Sodium caprate elicits dilatations in human intestinal tight junctions and enhances drug absorption by the paracellular route.

Authors:  E K Anderberg; T Lindmark; P Artursson
Journal:  Pharm Res       Date:  1993-06       Impact factor: 4.200

6.  Role of paracellular pathway in nonelectrolyte permeation across rat colon epithelium enhanced by sodium caprate and sodium caprylate.

Authors:  T Sawada; T Ogawa; M Tomita; M Hayashi; S Awazu
Journal:  Pharm Res       Date:  1991-11       Impact factor: 4.200

7.  Surface activity and concentration dependent intestinal permeability in the rat.

Authors:  A Lindahl; B Persson; A L Ungell; H Lennernäs
Journal:  Pharm Res       Date:  1999-01       Impact factor: 4.200

8.  Decanoic acid induced enhancement of rectal absorption of hydrophilic compounds in rats.

Authors:  K Takahashi; T Murakami; R Yumoto; T Hattori; Y Higashi; N Yata
Journal:  Pharm Res       Date:  1994-10       Impact factor: 4.200

9.  Pharmacokinetic analysis of the absorption enhancing action of decanoic acid and its derivatives in rats.

Authors:  K Takahashi; T Murakami; A Kamata; R Yumoto; Y Higashi; N Yata
Journal:  Pharm Res       Date:  1994-03       Impact factor: 4.200

10.  Evaluation of hydrophobic nanoparticulate delivery system for insulin.

Authors:  P S Singnurkar; S K Gidwani
Journal:  Indian J Pharm Sci       Date:  2008-11       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.